Latest News in the pharma Industry

Policy & Regulation

FDA Approves First Sublingual Allergen Extract for the Treatment of Certain Grass Pollen Allergies?

FDA Approves First Sublingual Allergen Extract for the Treatment of Certain Grass Pollen Allergies?

3 Apr 2014

Read more 
FDA Advisory Committee Recommends Approval of Afrezzar, MannKind Corporation's Investigational Drug to Treat Diabetes

FDA Advisory Committee Recommends Approval of Afrezzar, MannKind Corporation's Investigational Drug to Treat Diabetes

3 Apr 2014

Read more 
FDA Approves Biogen Idec's ALPROLIXT

FDA Approves Biogen Idec's ALPROLIXT

31 Mar 2014

Read more 
Rx-360 Summary of FDA's Guidance on Allowable Fill Volume Excesses in Vials

Rx-360 Summary of FDA's Guidance on Allowable Fill Volume Excesses in Vials

26 Mar 2014

Read more 
Forxiga Receives Regulatory Approval in Japan for the Treatment of Type 2 Diabetes

Forxiga Receives Regulatory Approval in Japan for the Treatment of Type 2 Diabetes

24 Mar 2014

Read more 
CHMP Recommends Empagliflozin for Approval to Reduce Blood Sugar Levels in Adults with Type 2 Diabetes in Europe

CHMP Recommends Empagliflozin for Approval to Reduce Blood Sugar Levels in Adults with Type 2 Diabetes in Europe

24 Mar 2014

Read more 
Biogen Idec Receives Notificati?on of PDUFA Date Extension for Plegridy (Peginterf?eron Beta-1a)

Biogen Idec Receives Notificati?on of PDUFA Date Extension for Plegridy (Peginterf?eron Beta-1a)

18 Mar 2014

Read more 
FDA Approves Merck’s NOXAFIL (Posaconazole) Injection (18 mg/mL) for Intravenous Use

FDA Approves Merck’s NOXAFIL (Posaconazole) Injection (18 mg/mL) for Intravenous Use

17 Mar 2014

Read more 
Actavis Confirms Favorable Ruling in Generic Celebrex Patent Suit

Actavis Confirms Favorable Ruling in Generic Celebrex Patent Suit

13 Mar 2014

Read more 
Rx-360 Summary of the First FDA Annual Report on the Inspection of Registered Establishm?ents

Rx-360 Summary of the First FDA Annual Report on the Inspection of Registered Establishm?ents

7 Mar 2014

Read more 
Baxter Initiates US Voluntary Recall of One Lot of Peritoneal Dialysis Solution Due to Container-Closure Non-Integrity

Baxter Initiates US Voluntary Recall of One Lot of Peritoneal Dialysis Solution Due to Container-Closure Non-Integrity

7 Mar 2014

Read more 
FDA Issues Complete Response Letter for Empagliflo?zin

FDA Issues Complete Response Letter for Empagliflo?zin

6 Mar 2014

Read more